Wave Life Sciences, Inc. (WVE) on GreekSoup

Wave Life Sciences, Inc. Q3 FY2025 results: revenue $8 million, net income -$54 million

Tue, 27 Oct 2026 00:00:00 +0000

Results. The filing. The page on GreekSoup.

Wave Life Sciences, Inc. Q3 FY2026 results: revenue $13 million, net income -$62 million

Tue, 27 Oct 2026 00:00:00 +0000

Results. The filing. The page on GreekSoup.

Wave Life Sciences, Inc. filed 10-Q: 10-q

Tue, 27 Oct 2026 00:00:00 +0000

SEC filing. The filing. The page on GreekSoup.

Wave Life Sciences, Inc. filed 8-K: results of operations

Tue, 27 Oct 2026 00:00:00 +0000

SEC filing. The filing. The page on GreekSoup.

Wave Life Sciences, Inc.: Schedule 13G filed by BlackRock, Inc., 6.8% of the class

Tue, 27 Oct 2026 00:00:00 +0000

Schedule 13D/13G. The filing. The page on GreekSoup.

Wave Life Sciences, Inc.: Schedule 13G/A filed by BlackRock, Inc., 0.0% of the class

Tue, 27 Oct 2026 00:00:00 +0000

Schedule 13D/13G. The filing. The page on GreekSoup.

Wave Life Sciences, Inc.: short interest 21,167,722 shares at the 15 October 2026 settlement, 6.53 days to cover

Thu, 15 Oct 2026 00:00:00 +0000

Short interest. The filing. The page on GreekSoup.

Wave Life Sciences, Inc. filed ARS: ars

Wed, 14 Oct 2026 00:00:00 +0000

SEC filing. The filing. The page on GreekSoup.

Wave Life Sciences, Inc. filed DEF 14A: def 14a

Wed, 14 Oct 2026 00:00:00 +0000

SEC filing. The filing. The page on GreekSoup.

Wave Life Sciences, Inc.: short interest 18,556,315 shares at the 30 September 2026 settlement, 5.70 days to cover

Wed, 30 Sep 2026 00:00:00 +0000

Short interest. The filing. The page on GreekSoup.

Wave Life Sciences, Inc.: short interest 17,637,783 shares at the 15 September 2026 settlement, 5.17 days to cover

Tue, 15 Sep 2026 00:00:00 +0000

Short interest. The filing. The page on GreekSoup.

Wave Life Sciences, Inc.: short interest 16,281,873 shares at the 31 August 2026 settlement, 5.49 days to cover

Mon, 31 Aug 2026 00:00:00 +0000

Short interest. The filing. The page on GreekSoup.

Wave Life Sciences, Inc.: short interest 16,200,874 shares at the 14 August 2026 settlement, 4.39 days to cover

Fri, 14 Aug 2026 00:00:00 +0000

Short interest. The filing. The page on GreekSoup.

Wave Life Sciences, Inc.: Rawcliffe Adrian (Director) sold 12,700 shares (under a trading plan set in advance) at $5.29 on 12 August 2026, $67,183

Thu, 13 Aug 2026 00:00:00 +0000

Insider trade. The filing. The page on GreekSoup.

Wave Life Sciences, Inc.: Wagner Heidi L (Director) sold 7,000 shares (under a trading plan set in advance) at $6.01 on 11 August 2026, $42,070

Thu, 13 Aug 2026 00:00:00 +0000

Insider trade. The filing. The page on GreekSoup.

Wave Life Sciences, Inc.: Takanashi Ken (Director) sold 3,864 shares (under a trading plan set in advance) at $6.01 on 11 August 2026, $23,223

Thu, 13 Aug 2026 00:00:00 +0000

Insider trade. The filing. The page on GreekSoup.

Wave Life Sciences, Inc.: Tan Aik Na (Director) sold 432 shares (under a trading plan set in advance) at $6.01 on 11 August 2026, $2,596

Thu, 13 Aug 2026 00:00:00 +0000

Insider trade. The filing. The page on GreekSoup.

Wave Life Sciences, Inc.: Form 144, ADRIAN G RAWCLIFFE plans to sell 12,700 shares worth $64,072 around 12 August 2026

Wed, 12 Aug 2026 00:00:00 +0000

Form 144. The filing. The page on GreekSoup.

Wave Life Sciences, Inc.: Form 144, HEIDI L WAGNER plans to sell 7,000 shares worth $42,490 around 11 August 2026

Tue, 11 Aug 2026 00:00:00 +0000

Form 144. The filing. The page on GreekSoup.

Wave Life Sciences, Inc.: Schedule 13D/A filed by RA Capital Management, L.P., 16.8% of the class

Tue, 11 Aug 2026 00:00:00 +0000

Item 4 of the Statement is hereby amended and supplemented as follows: On August 7, 2026, as part of the Redomiciliation, Wave-Delaware, became the ultimate parent company of the Wave Life Sciences group of companies. Pursuant to the Scheme of Arrangement, all issued ordinary shares in the capital of Wave Life Sciences Ltd. ("Wave-Singapore") as of immediately prior to the effective time of the Scheme of Arrangement were exchanged on a one-for-one basis for newly issued shares of common stock, par value $0.001 per share, of Wave-Delaware, and Wave-Singapore became a wholly owned subsidiary of

Schedule 13D/13G. The filing. The page on GreekSoup.